Overview

  • Product nameAnti-RBM35A + RBM35B antibody [23A7.C9]
  • Description
    Mouse monoclonal [23A7.C9] to RBM35A + RBM35B
  • Specificityab106555 recognises both Mouse RBM35A and RBM35B.
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Mouse
    Predicted to work with: Rat, Horse, Cow, Dog, Human, Pig, Chimpanzee, Opossum
  • Immunogen

    Recombinant full length Mouse RBM35A with a proprietary tag (NP_918944.2).

  • Positive control
    • RBM35A or RBM35B transfected 293T cell extracts

Properties

  • FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • Storage bufferpH: 7.20
    Preservative: 0.01% Sodium azide
    Constituents: 0.42% Potassium phosphate, 0.88% Sodium chloride
  • Concentration information loading...
  • PurityProtein A purified
  • Purification notesab106555 was purified from tissue culture supernatant by Protein A chromatography followed by extensive dialysis against the buffer stated. The antibody is sterile filtered.
  • ClonalityMonoclonal
  • Clone number23A7.C9
  • IsotypeIgG1

Applications

Our Abpromise guarantee covers the use of ab106555 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/1000. Predicted molecular weight: 76, 77 kDa.

Target

Anti-RBM35A + RBM35B antibody [23A7.C9] images

  • All lanes : Anti-RBM35A + RBM35B antibody [23A7.C9] (ab106555) at 1/1000 dilution

    Lane 1 : GFP transfected 293T cell extract
    Lane 2 : RBM35A transfected 293T cell extract
    Lane 3 : RBM35B transfected 293T cell extract

    Lysates/proteins at 5 µg per lane.

    Secondary
    anti-mouse ECL antibody at 1/10000 dilution
    Developed using the ECL technique

    Predicted band size : 76, 77 kDa

References for Anti-RBM35A + RBM35B antibody [23A7.C9] (ab106555)

This product has been referenced in:
  • Warzecha CC  et al. An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition. EMBO J 29:3286-300 (2010). Read more (PubMed: 20711167) »

See 1 Publication for this product

Product Wall

There are currently no Abreviews or Questions for ab106555.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"